Testing effectiveness (Phase 2)Study completedNCT00707967
What this trial is testing
Safety and Immunogenicity of a Candidate Tuberculosis (TB) Vaccine in HIV-positive Adults.
Who this might be right for
Tuberculosis
GlaxoSmithKline 37
Showing 20 of 351 results